Arrowhead Pharmaceuticals Inc.

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
Analyst consensus
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc develops medicines using its targeted RNAi molecule, TRiM, platform that uses a natural pathway to silence genes causing disease. It has commercialized Redemplo (plozasiran) as an adjunct to diet to reduce triglycerides (TGs) in adults with Familial Chylomicronemia Syndrome (FCS). Redemplo has received marketing authorization for FCS across the European Union, the USA, Canada, Australia, China, and the United Kingdom. It has several drug candidates in clinical trials ranging from early to late stage, including both partnered and wholly-owned candidates such as Zodasiran, Olpasiran, Fazirsiran, ARO-C3, and others being developed as therapies for various cardiometabolic, pulmonary, liver, neuromuscular, and other conditions. It operates as a single segment.
Frequently asked questions
To buy Arrowhead Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Arrowhead Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Arrowhead Pharmaceuticals Inc. is ARWR. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Arrowhead Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Arrowhead Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Arrowhead Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Arrowhead Pharmaceuticals Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Arrowhead Pharmaceuticals Inc. or others.